,coef,coef_graph,coef_combined,coef_combined_zscore,coef_combined2
Phase II - Conjugation of compounds,2.6284556e-06,7.0,2.6284556e-06,-0.2294626,-0.7737814
Energy dependent regulation of mTOR by LKB1-AMPK,1.8494993e-05,2.0,1.8494993e-05,-0.22308214,0.07542767
TCR signaling,2.5294148e-06,5.0,2.5294148e-06,-0.22950244,-0.43595695
Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA,5.4933185e-08,2.0,5.4933185e-08,-0.23049751,0.07010891
Switching of origins to a post-replicative state,0.00050953403,3.0,0.00050953403,-0.025618928,0.048133757
Eukaryotic Translation Termination,3.315299e-05,2.0,3.315299e-05,-0.21718767,0.079655536
Small interfering RNA (siRNA) biogenesis,2.6150147e-07,2.0,2.6150147e-07,-0.23041444,0.070168495
Mitochondrial ABC transporters,1.968489e-05,2.0,1.968489e-05,-0.22260365,0.07577087
Thrombin signalling through proteinase activated receptors (PARs),0.000109611436,2.0,0.000109611436,-0.18644118,0.10170878
Interconversion of nucleotide di- and triphosphates,0.0008419372,2.0,0.0008419372,0.1080515,0.31293684
DNA Replication Pre-Initiation,0.0027472859,3.0,0.0027472859,0.8742559,0.6935787
RNA Polymerase I Transcription Termination,2.2992217e-06,2.0,2.2992217e-06,-0.22959502,0.07075623
ChREBP activates metabolic gene expression,6.316495e-07,2.0,6.316495e-07,-0.23026559,0.07027526
Mitotic G2-G2/M phases,0.00033661883,3.0,0.00033661883,-0.09515391,-0.0017409605
Signaling by BMP,1.9437753e-06,2.0,1.9437753e-06,-0.22973794,0.07065372
Mitochondrial translation,4.828599e-05,4.0,4.828599e-05,-0.21110219,-0.25383264
Metabolism of water-soluble vitamins and cofactors,0.00020243171,11.0,0.00020243171,-0.14911504,-1.3918574
Ketone body metabolism,1.0206712e-07,3.0,1.0206712e-07,-0.23047857,-0.098804034
Wax biosynthesis,2.3664863e-09,2.0,2.3664863e-09,-0.23051864,0.07009375
Mitochondrial transcription initiation,6.7223094e-09,2.0,6.7223094e-09,-0.23051691,0.070094995
Synthesis of pyrophosphates in the cytosol,1.6695928e-10,2.0,1.6695928e-10,-0.23051953,0.07009311
Growth hormone receptor signaling,8.559534e-07,2.0,8.559534e-07,-0.23017539,0.070339955
Molecules associated with elastic fibres,2.3262866e-05,2.0,2.3262866e-05,-0.22116482,0.07680287
Signaling by NOTCH3,2.1791232e-06,3.0,2.1791232e-06,-0.2296433,-0.09820493
SLC transporter disorders,4.1777666e-06,73.0,5.722968e-08,-0.23049659,-11.922483
Neurexins and neuroligins,1.1796012e-07,2.0,1.1796012e-07,-0.23047215,0.0701271
Intestinal lipid absorption,0.0,2.0,0.0,-0.2305196,0.07009306
Defective Mismatch Repair Associated With MSH6,1.6552734e-08,2.0,1.6552734e-08,-0.23051295,0.070097834
Inwardly rectifying K+ channels,3.6658093e-05,5.0,3.6658093e-05,-0.21577816,-0.42611307
Defective Mismatch Repair Associated With PMS2,1.1467374e-09,2.0,1.1467374e-09,-0.23051913,0.0700934
NCAM signaling for neurite out-growth,2.4385392e-06,2.0,2.4385392e-06,-0.22953898,0.07079643
PECAM1 interactions,7.050403e-09,2.0,7.050403e-09,-0.23051676,0.0700951
Synaptic adhesion-like molecules,1.401064e-05,2.0,1.401064e-05,-0.22488545,0.074134216
"Synthesis, secretion, and deacylation of Ghrelin",3.5091578e-06,2.0,3.5091578e-06,-0.22910845,0.07110523
LGI-ADAM interactions,1.06223075e-08,2.0,1.06223075e-08,-0.23051535,0.07009612
Aflatoxin activation and detoxification,8.185631e-08,2.0,8.185631e-08,-0.23048669,0.07011667
Defective Mismatch Repair Associated With MLH1,5.2467212e-06,2.0,5.2467212e-06,-0.22840972,0.0716064
Glycogen metabolism,5.0336395e-05,3.0,5.0336395e-05,-0.21027765,-0.084314704
Fructose metabolism,1.2962918e-05,3.0,1.2962918e-05,-0.22530678,-0.09509452
IP3 and IP4 transport between cytosol and nucleus,0.0,2.0,0.0,-0.2305196,0.07009306
EPH-Ephrin signaling,6.6236775e-05,5.0,6.6236775e-05,-0.20388357,-0.41758156
Post-transcriptional silencing by small RNAs,1.2403181e-07,2.0,1.2403181e-07,-0.23046972,0.07012884
Signaling by FGFR,0.009248679,5.0,0.009248679,3.4886835,2.230952
Sperm:Oocyte Membrane Binding,3.4368092e-08,2.0,3.4368092e-08,-0.2305058,0.07010297
Signaling by Hippo,1.06366365e-07,2.0,1.06366365e-07,-0.23047684,0.07012373
Interaction With Cumulus Cells,0.0,2.0,0.0,-0.2305196,0.07009306
TCF dependent signaling in response to WNT,0.003606311,10.0,0.003606311,1.2196987,-0.24113439
Abacavir transmembrane transport,0.0,2.0,0.0,-0.2305196,0.07009306
Choline catabolism,1.281866e-06,2.0,1.281866e-06,-0.23000413,0.07046279
Hedgehog 'on' state,7.42963e-05,4.0,7.42963e-05,-0.20064257,-0.24633037
Rap1 signalling,0.0002398558,2.0,0.0002398558,-0.13406557,0.13927576
Nitric oxide stimulates guanylate cyclase,1.832392e-05,2.0,1.832392e-05,-0.22315092,0.07537832
Response to elevated platelet cytosolic Ca2+,6.9545065e-05,3.0,6.9545065e-05,-0.20255321,-0.078774266
Cytosolic sensors of pathogen-associated DNA ,3.1012764e-06,6.0,3.1012764e-06,-0.22927245,-0.6047185
ABC transporters in lipid homeostasis,0.0004442948,2.0,0.0004442948,-0.051853806,0.19824305
Regulation of mitotic cell cycle,8.272155e-06,2.0,8.272155e-06,-0.22719307,0.072479054
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),1.2478233e-06,2.0,1.2478233e-06,-0.23001783,0.070452966
Cellular response to heat stress,5.3684624e-05,4.0,5.3684624e-05,-0.20893121,-0.25227547
Fc epsilon receptor (FCERI) signaling,0.0002657319,5.0,0.0002657319,-0.12365991,-0.36004028
Macroautophagy,1.7029549e-06,2.0,1.7029549e-06,-0.22983478,0.07058426
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,1.6431542e-05,6.0,1.6431542e-05,-0.22391193,-0.6008736
Sphingolipid metabolism,3.0242936e-05,3.0,3.0242936e-05,-0.21835789,-0.090110354
DNA methylation,3.0777153e-06,2.0,3.0777153e-06,-0.22928195,0.07098079
Processing of Intronless Pre-mRNAs,1.1039634e-05,2.0,1.1039634e-05,-0.22608021,0.073277265
mRNA Editing: A to I Conversion,5.326804e-07,3.0,5.326804e-07,-0.2303054,-0.09867983
ATF6 (ATF6-alpha) activates chaperones,7.1068653e-06,2.0,7.1068653e-06,-0.2276617,0.07214294
Regulation of insulin secretion,8.885114e-07,5.0,8.885114e-07,-0.2301623,-0.43643025
ABC transporter disorders,0.0002380457,16.0,0.0002380457,-0.13479346,-2.2262175
Uptake and actions of bacterial toxins,2.3508703e-06,5.0,2.3508703e-06,-0.22957423,-0.43600845
Integrin alphaIIb beta3 signaling,0.0020502238,3.0,0.0020502238,0.5939439,0.4925219
Protein methylation,0.0011661074,2.0,0.0011661074,0.23841116,0.4064387
Transcriptional activation of mitochondrial biogenesis,6.795121e-05,2.0,6.795121e-05,-0.20319414,0.08969254
WNT ligand biogenesis and trafficking,3.002212e-06,2.0,3.002212e-06,-0.2293123,0.07095901
Nucleosome assembly,0.007901548,2.0,0.007901548,2.946957,2.3491726
Mitotic G1-G1/S phases,0.002476403,4.0,0.002476403,0.76532483,0.4465202
"TET1,2,3 and TDG demethylate DNA",1.5552679e-10,2.0,1.5552679e-10,-0.23051953,0.07009311
Tandem pore domain potassium channels,2.6946952e-07,7.0,2.6946952e-07,-0.23041125,-0.77446175
MicroRNA (miRNA) biogenesis,2.5209104e-09,2.0,2.5209104e-09,-0.2305186,0.07009379
Formation of the cornified envelope,1.3632653e-06,2.0,1.3632653e-06,-0.22997138,0.070486285
Signaling by Interleukins,0.0011197212,12.0,0.0011197212,0.21975775,-1.2962058
Toll-Like Receptors Cascades,0.00018221329,10.0,0.00018221329,-0.15724555,-1.2287624
Defective Mismatch Repair Associated With MSH3,7.957759e-06,2.0,7.957759e-06,-0.22731952,0.07238835
Eukaryotic Translation Initiation,0.011856045,3.0,0.011856045,4.5371923,3.3208597
IP6 and IP7 transport between cytosol and nucleus,0.0,2.0,0.0,-0.2305196,0.07009306
Signaling by Leptin,4.8888232e-06,2.0,4.8888232e-06,-0.22855365,0.07150316
Diseases of carbohydrate metabolism,3.22648e-08,8.0,3.22648e-08,-0.23050663,-0.9434568
tRNA Aminoacylation,0.0007623209,3.0,0.0007623209,0.07603512,0.12104621
Hedgehog 'off' state,0.0004055188,4.0,0.0004055188,-0.06744693,-0.15079436
GPVI-mediated activation cascade,2.6537355e-05,2.0,2.6537355e-05,-0.21984805,0.07774735
MAPK6/MAPK4 signaling,0.002247415,2.0,0.002247415,0.6732411,0.71832526
Class I MHC mediated antigen processing & presentation,3.8718776e-05,4.0,3.8718776e-05,-0.2149495,-0.25659215
Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate,6.2928796e-10,2.0,6.2928796e-10,-0.23051934,0.07009325
Metabolism of cofactors,6.544263e-07,4.0,6.544263e-07,-0.23025644,-0.2675712
Detoxification of Reactive Oxygen Species,6.366442e-05,2.0,6.366442e-05,-0.20491801,0.08845607
Signaling by NTRKs,0.0002805655,5.0,0.0002805655,-0.11769483,-0.35576174
Mitochondrial transcription termination,6.77274e-07,2.0,6.77274e-07,-0.23024726,0.070288405
Platelet Aggregation (Plug Formation),2.690691e-06,2.0,2.690691e-06,-0.22943757,0.070869155
Diseases associated with the TLR signaling cascade,0.0012210554,12.0,0.0012210554,0.2605076,-1.2669777
IPs transport between ER lumen and nucleus,0.0,2.0,0.0,-0.2305196,0.07009306
Intestinal hexose absorption,0.0,2.0,0.0,-0.2305196,0.07009306
Receptor Mediated Mitophagy,7.233475e-07,2.0,7.233475e-07,-0.23022872,0.070301704
AUF1 (hnRNP D0) binds and destabilizes mRNA,0.0001486169,2.0,0.0001486169,-0.17075577,0.11295931
Striated Muscle Contraction,3.1441482e-07,2.0,3.1441482e-07,-0.23039316,0.07018376
Melanin biosynthesis,0.0,2.0,0.0,-0.2305196,0.07009306
Glucose metabolism,2.9565563e-06,3.0,2.9565563e-06,-0.22933067,-0.09798069
Pentose phosphate pathway,2.8589e-08,2.0,2.8589e-08,-0.2305081,0.07010131
Signaling by Activin,3.6633148e-07,2.0,3.6633148e-07,-0.23037228,0.07019873
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells,7.81193e-06,2.0,7.81193e-06,-0.22737816,0.07234629
Platelet calcium homeostasis,6.089559e-06,3.0,6.089559e-06,-0.22807078,-0.09707703
Protein ubiquitination,0.000436361,3.0,0.000436361,-0.05504425,0.027028125
Basigin interactions,0.00924211,2.0,0.00924211,3.486042,2.7358367
ESR-mediated signaling,0.00012148704,2.0,0.00012148704,-0.1816656,0.105134115
SRP-dependent cotranslational protein targeting to membrane,0.00052586175,2.0,0.00052586175,-0.019053007,0.22176977
Signaling by NOTCH1,0.00084826164,3.0,0.00084826164,0.11059477,0.14583449
TRAIL  signaling,9.354485e-05,2.0,9.354485e-05,-0.19290209,0.09707462
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,3.360884e-05,2.0,3.360884e-05,-0.21700437,0.079787016
"Transport of bile salts and organic acids, metal ions and amine compounds",2.764253e-05,8.0,2.764253e-05,-0.21940361,-0.9354931
Galactose catabolism,6.930061e-06,2.0,6.930061e-06,-0.22773278,0.072091945
Prolactin receptor signaling,3.0127058e-08,2.0,3.0127058e-08,-0.23050748,0.07010176
Plasmalogen biosynthesis,6.3330916e-08,2.0,6.3330916e-08,-0.23049413,0.070111334
Integrin cell surface interactions,0.00010424268,2.0,0.00010424268,-0.18860014,0.10016025
Glyoxylate metabolism and glycine degradation,2.437468e-05,2.0,2.437468e-05,-0.22071773,0.07712357
RIPK1-mediated regulated necrosis,0.0018479571,2.0,0.0018479571,0.5126058,0.60310775
Lactose synthesis,1.2936265e-07,2.0,1.2936265e-07,-0.23046759,0.07013037
Amyloid fiber formation,0.036061227,2.0,0.036061227,14.270906,10.471397
Effects of PIP2 hydrolysis,5.5308396e-07,2.0,5.5308396e-07,-0.23029718,0.0702526
DDX58/IFIH1-mediated induction of interferon-alpha/beta,0.0002879802,6.0,0.0002879802,-0.11471313,-0.5225496
Homology Directed Repair,0.0005792156,3.0,0.0005792156,0.002402356,0.06823233
Clathrin-mediated endocytosis,0.00026914864,2.0,0.00026914864,-0.12228593,0.14772482
Antimicrobial peptides,2.4668516e-06,4.0,2.4668516e-06,-0.22952761,-0.26704845
Passive transport by Aquaporins,4.3875905e-05,2.0,4.3875905e-05,-0.21287563,0.08274839
mRNA Splicing,4.8997023e-05,3.0,4.8997023e-05,-0.21081626,-0.08470103
Deadenylation of mRNA,1.0131116e-07,2.0,1.0131116e-07,-0.23047885,0.070122294
Dissolution of Fibrin Clot,1.070265e-06,2.0,1.070265e-06,-0.23008922,0.07040176
Transcription-Coupled Nucleotide Excision Repair (TC-NER),0.016741855,4.0,0.016741855,6.50194,4.561169
Cellular response to hypoxia,7.440016e-05,2.0,7.440016e-05,-0.2006008,0.09155264
Phase 0 - rapid depolarisation,2.7074015e-05,2.0,2.7074015e-05,-0.21963224,0.077902146
PRC2 methylates histones and DNA,9.2837394e-07,2.0,9.2837394e-07,-0.23014627,0.07036084
Cristae formation,8.619311e-07,2.0,8.619311e-07,-0.23017299,0.07034168
Kinesins,5.2402233e-06,2.0,5.2402233e-06,-0.22841235,0.07160451
"Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism",8.499629e-08,6.0,8.499629e-08,-0.23048542,-0.60558856
Nonhomologous End-Joining (NHEJ),0.0009805087,2.0,0.0009805087,0.16377576,0.3529057
Invadopodia formation,6.4340493e-06,2.0,6.4340493e-06,-0.22793226,0.07194886
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),7.1573695e-06,2.0,7.1573695e-06,-0.22764137,0.0721575
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),3.1521947e-07,2.0,3.1521947e-07,-0.23039284,0.070183985
RHO GTPase Effectors,0.0016811901,12.0,0.0016811901,0.44554317,-1.1342589
Rab regulation of trafficking,5.0295403e-05,3.0,5.0295403e-05,-0.21029414,-0.084326535
Signaling by MET,4.918873e-05,9.0,4.918873e-05,-0.21073917,-1.098205
PIP3 activates AKT signaling,0.0011124876,5.0,0.0011124876,0.21684888,-0.11580665
RNA Polymerase II Transcription Elongation,1.0804773e-06,3.0,1.0804773e-06,-0.23008512,-0.09852183
Pyrophosphate hydrolysis,2.1467054e-06,2.0,2.1467054e-06,-0.22965634,0.070712246
Synthesis of IP3 and IP4 in the cytosol,0.00039280692,2.0,0.00039280692,-0.072558805,0.18339217
Type I hemidesmosome assembly,8.5457253e-07,2.0,8.5457253e-07,-0.23017596,0.070339546
PIWI-interacting RNA (piRNA) biogenesis,3.9546189e-10,2.0,3.9546189e-10,-0.23051943,0.07009318
Phase 3 - rapid repolarisation,3.6852516e-08,2.0,3.6852516e-08,-0.23050478,0.0701037
TNFR2 non-canonical NF-kB pathway,4.3182867e-05,4.0,4.3182867e-05,-0.21315433,-0.25530455
Oncogenic MAPK signaling,3.8695605e-05,7.0,3.8695605e-05,-0.21495882,-0.7633784
Reversal of alkylation damage by DNA dioxygenases,3.6294413e-08,3.0,3.6294413e-08,-0.23050499,-0.09882299
S Phase,0.00012589086,4.0,0.00012589086,-0.17989467,-0.2314487
Fibronectin matrix formation,0.0,2.0,0.0,-0.2305196,0.07009306
Intra-Golgi and retrograde Golgi-to-ER traffic,0.010177215,4.0,0.010177215,3.862079,2.6677005
Synthesis of IPs in the nucleus,2.2520883e-09,2.0,2.2520883e-09,-0.23051868,0.07009372
Global Genome Nucleotide Excision Repair (GG-NER),0.00036110118,5.0,0.00036110118,-0.08530874,-0.33253247
Intraflagellar transport,0.00024372226,2.0,0.00024372226,-0.13251074,0.14039098
Ca2+ activated K+ channels,1.1510059e-06,2.0,1.1510059e-06,-0.23005675,0.07042505
HCN channels,5.8534956e-06,2.0,5.8534956e-06,-0.22816572,0.07178141
RMTs methylate histone arginines,2.2216256e-08,2.0,2.2216256e-08,-0.23051065,0.07009947
Physiological factors,3.5669627e-06,2.0,3.5669627e-06,-0.2290852,0.0711219
Defective Mismatch Repair Associated With MSH2,6.7562183e-09,2.0,6.7562183e-09,-0.23051688,0.07009502
Lipid particle organization,3.6729972e-07,2.0,3.6729972e-07,-0.2303719,0.070199
Defects in vitamin and cofactor metabolism,4.411248e-06,3.0,4.411248e-06,-0.22874568,-0.097561106
Activation of PPARGC1A (PGC-1alpha) by phosphorylation,5.378834e-06,2.0,5.378834e-06,-0.22835658,0.07164451
Signaling by EGFR,9.979211e-05,6.0,9.979211e-05,-0.19038986,-0.57682955
HDMs demethylate histones,1.6243953e-07,2.0,1.6243953e-07,-0.23045427,0.07013993
"Transport of vitamins, nucleosides, and related molecules",8.07054e-06,5.0,8.07054e-06,-0.22727416,-0.43435872
DNA Double Strand Break Response,0.00033858212,3.0,0.00033858212,-0.094364405,-0.0011746831
RNA Polymerase II Transcription Initiation And Promoter Clearance,3.121251e-07,3.0,3.121251e-07,-0.2303941,-0.098743446
MHC class II antigen presentation,3.7971327e-05,2.0,3.7971327e-05,-0.21525007,0.0810453
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),4.0384148e-06,2.0,4.0384148e-06,-0.22889563,0.071257874
eNOS activation and regulation,3.7292088e-05,4.0,3.7292088e-05,-0.21552321,-0.25700366
HSP90 chaperone cycle for steroid hormone receptors (SHR),2.1703494e-05,2.0,2.1703494e-05,-0.22179191,0.0763531
Listeria monocytogenes entry into host cells,3.783234e-05,3.0,3.783234e-05,-0.21530594,-0.0879213
Nucleobase catabolism,1.2967973e-06,4.0,1.2967973e-06,-0.22999811,-0.26738593
Mitochondrial protein import,1.3054892e-05,2.0,1.3054892e-05,-0.2252698,0.073858544
Mitotic Spindle Checkpoint,4.4120137e-05,3.0,4.4120137e-05,-0.21277742,-0.08610769
Scavenging by Class H Receptors,6.0866594e-05,2.0,6.0866594e-05,-0.20604311,0.08764909
Acrosome Reaction,0.0,2.0,0.0,-0.2305196,0.07009306
mRNA Editing: C to U Conversion,1.8731718e-05,2.0,1.8731718e-05,-0.22298697,0.075495936
Assembly of collagen fibrils and other multimeric structures,4.1896616e-05,3.0,4.1896616e-05,-0.21367158,-0.08674904
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),6.117135e-07,2.0,6.117135e-07,-0.23027362,0.070269495
Sulfur amino acid metabolism,1.4502784e-05,4.0,1.4502784e-05,-0.22468755,-0.2635769
Signaling by Insulin receptor,0.00037192213,3.0,0.00037192213,-0.08095728,0.0084417295
Electron transport from NADPH to Ferredoxin,1.5119689e-05,2.0,1.5119689e-05,-0.22443947,0.0744541
Reelin signalling pathway,3.9718012e-07,2.0,3.9718012e-07,-0.23035987,0.07020763
Fcgamma receptor (FCGR) dependent phagocytosis,0.00032089106,4.0,0.00032089106,-0.10147857,-0.17520392
TNF signaling,0.00022890193,5.0,0.00022890193,-0.13847049,-0.37066332
ECM proteoglycans,1.6257283e-05,2.0,1.6257283e-05,-0.223982,0.07478223
Deubiquitination,0.0017508948,6.0,0.0017508948,0.47357374,-0.10059447
Signaling by TGF-beta Receptor Complex in Cancer,0.00017372558,5.0,0.00017372558,-0.16065873,-0.38657805
Regulation of gene expression in early pancreatic precursor cells,0.0,2.0,0.0,-0.2305196,0.07009306
tRNA modification in the mitochondrion,4.5320658e-06,2.0,4.5320658e-06,-0.2286971,0.07140027
NR1D1 (REV-ERBA) represses gene expression,2.7379253e-06,2.0,2.7379253e-06,-0.22941859,0.070882775
L1CAM interactions,4.3622e-06,7.0,4.3622e-06,-0.22876541,-0.7732813
MTF1 activates gene expression,4.0004765e-05,2.0,4.0004765e-05,-0.21443234,0.081631824
Erythrocytes take up carbon dioxide and release oxygen,0.001256009,2.0,0.001256009,0.2745636,0.43236944
HATs acetylate histones,5.6663157e-05,2.0,5.6663157e-05,-0.20773344,0.08643668
PKA-mediated phosphorylation of key metabolic factors,3.4267714e-08,2.0,3.4267714e-08,-0.23050581,0.07010296
RNA Polymerase I Chain Elongation,7.394284e-06,2.0,7.394284e-06,-0.22754611,0.07222583
Scavenging by Class B Receptors,4.3445045e-05,2.0,4.3445045e-05,-0.2130489,0.082624115
Phase 2 - plateau phase,0.0044622794,2.0,0.0044622794,1.5639122,1.3571687
Meiotic recombination,7.66501e-05,2.0,7.66501e-05,-0.19969602,0.092201605
Triglyceride metabolism,5.5319816e-07,3.0,5.5319816e-07,-0.23029713,-0.098673895
Lysosomal oligosaccharide catabolism,7.769863e-07,2.0,7.769863e-07,-0.23020713,0.07031719
tRNA processing in the nucleus,3.208066e-05,2.0,3.208066e-05,-0.21761888,0.07934625
PI3K/AKT Signaling in Cancer,4.578953e-06,4.0,4.578953e-06,-0.22867824,-0.26643926
FasL/ CD95L signaling,0.00010224643,2.0,0.00010224643,-0.1894029,0.09958445
Digestion of dietary carbohydrate,0.004696379,2.0,0.004696379,1.6580514,1.4246911
SUMOylation,0.0028491602,3.0,0.0028491602,0.915223,0.7229628
Processing of SMDT1,0.0003207326,2.0,0.0003207326,-0.1015423,0.16260342
rRNA processing in the nucleus and cytosol,7.8325155e-07,3.0,7.8325155e-07,-0.23020463,-0.09860755
Abacavir metabolism,9.403084e-08,2.0,9.403084e-08,-0.2304818,0.07012018
Hh mutants abrogate ligand secretion,1.6880387e-05,3.0,1.6880387e-05,-0.22373143,-0.093964584
RAB geranylgeranylation,0.00081148103,2.0,0.00081148103,0.09580406,0.30415225
RNA Polymerase II Transcription Termination,6.528474e-09,2.0,6.528474e-09,-0.23051699,0.07009494
snRNP Assembly,0.0004721977,2.0,0.0004721977,-0.04063312,0.2062912
Amino acid synthesis and interconversion (transamination),6.434317e-05,2.0,6.434317e-05,-0.20464507,0.08865186
"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.",0.0013431181,4.0,0.0013431181,0.3095931,0.11964168
tRNA modification in the nucleus and cytosol,3.3328638e-07,2.0,3.3328638e-07,-0.23038557,0.0701892
Collagen degradation,0.0010219543,2.0,0.0010219543,0.18044242,0.36485997
Selenoamino acid metabolism,5.376861e-06,8.0,5.376861e-06,-0.22835737,-0.9419152
Nephrin family interactions,2.6412034e-05,2.0,2.6412034e-05,-0.21989845,0.0777112
Costimulation by the CD28 family,1.38514615e-05,4.0,1.38514615e-05,-0.22494946,-0.26376474
Asparagine N-linked glycosylation,1.036595e-05,4.0,1.036595e-05,-0.2263511,-0.2647701
Plasma lipoprotein clearance,7.87802e-05,6.0,7.87802e-05,-0.19883946,-0.5828901
Pre-NOTCH Expression and Processing,0.0012190075,4.0,0.0012190075,0.2596841,0.08384391
G2/M Checkpoints,5.8619893e-08,4.0,5.8619893e-08,-0.23049603,-0.26774308
"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation",6.856707e-07,2.0,6.856707e-07,-0.23024386,0.07029084
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha),4.3874744e-11,2.0,4.3874744e-11,-0.23051958,0.07009308
Reversible hydration of carbon dioxide,0.0003048603,2.0,0.0003048603,-0.10792508,0.15802531
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA,2.285161e-05,2.0,2.285161e-05,-0.2213302,0.07668427
Negative epigenetic regulation of rRNA expression,5.330883e-07,3.0,5.330883e-07,-0.23030524,-0.098679714
Post-translational protein phosphorylation,1.6903747e-05,2.0,1.6903747e-05,-0.22372204,0.07496868
Signaling by PTK6,0.0021013569,10.0,0.0021013569,0.61450624,-0.67521524
Syndecan interactions,0.0010024848,2.0,0.0010024848,0.17261307,0.35924432
"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",5.3317854e-06,2.0,5.3317854e-06,-0.22837552,0.071630925
"POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation",0.0004274167,2.0,0.0004274167,-0.058641054,0.19337481
Miscellaneous transport and binding events,8.325111e-08,2.0,8.325111e-08,-0.23048612,0.07011708
GPCR downstream signalling,0.0024597922,7.0,0.0024597922,0.75864506,-0.06505049
RNA Polymerase III Transcription Initiation,2.5582045e-07,4.0,2.5582045e-07,-0.23041673,-0.2676862
Transcriptional regulation by small RNAs,2.8698798e-07,2.0,2.8698798e-07,-0.2304042,0.07017584
mRNA decay by 5' to 3' exoribonuclease,9.123209e-08,2.0,9.123209e-08,-0.23048292,0.07011937
Degradation of beta-catenin by the destruction complex,0.0009722067,3.0,0.0009722067,0.16043723,0.18158455
Diseases associated with N-glycosylation of proteins,5.043453e-13,17.0,5.043453e-13,-0.2305196,-2.4638047
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,7.797781e-06,2.0,7.797781e-06,-0.22738385,0.07234221
Phospholipid metabolism,4.2841552e-06,3.0,4.2841552e-06,-0.22879681,-0.09759778
Neurotransmitter clearance,6.3468133e-09,3.0,6.3468133e-09,-0.23051704,-0.09883163
Glycosaminoglycan metabolism,2.3224184e-05,6.0,2.3224184e-05,-0.2211804,-0.5989144
Synthesis of IPs in the ER lumen,0.0,2.0,0.0,-0.2305196,0.07009306
Beta-catenin independent WNT signaling,0.00012837809,3.0,0.00012837809,-0.17889448,-0.06180478
DNA replication initiation,1.5063897e-06,2.0,1.5063897e-06,-0.22991382,0.07052757
Plasma lipoprotein remodeling,3.1095572e-06,5.0,3.1095572e-06,-0.22926913,-0.43578961
GPCR ligand binding,0.00054301484,4.0,0.00054301484,-0.012155172,-0.11113575
Telomere Maintenance,0.0023049864,3.0,0.0023049864,0.6963925,0.56600416
Digestion of dietary lipid,2.3698278e-05,2.0,2.3698278e-05,-0.22098973,0.07692846
Diseases associated with O-glycosylation of proteins,2.0826236e-07,10.0,2.0826236e-07,-0.23043585,-1.2812591
RNA Pol II CTD phosphorylation and interaction with CE,4.7705242e-08,2.0,4.7705242e-08,-0.2305004,0.070106834
RORA activates gene expression,2.363976e-05,2.0,2.363976e-05,-0.22101326,0.07691159
IPs transport between cytosol and ER lumen,0.0,2.0,0.0,-0.2305196,0.07009306
Collagen biosynthesis and modifying enzymes,0.00034013504,2.0,0.00034013504,-0.09373993,0.16819975
rRNA processing in the mitochondrion,7.559148e-07,2.0,7.559148e-07,-0.23021561,0.07031111
Erythrocytes take up oxygen and release carbon dioxide,0.00030746983,2.0,0.00030746983,-0.106875695,0.15877797
PERK regulates gene expression,1.1812995e-08,2.0,1.1812995e-08,-0.23051485,0.07009647
Common Pathway of Fibrin Clot Formation,0.0,2.0,0.0,-0.2305196,0.07009306
RNA Polymerase III Chain Elongation,1.125072e-05,2.0,1.125072e-05,-0.2259953,0.073338166
Transport of inorganic cations/anions and amino acids/oligopeptides,0.020564793,11.0,0.020564793,8.039271,4.4813514
Transport of glycerol from adipocytes to the liver by Aquaporins,0.0,2.0,0.0,-0.2305196,0.07009306
Peptide hormone biosynthesis,0.0,2.0,0.0,-0.2305196,0.07009306
Cellular hexose transport,5.962837e-07,2.0,5.962837e-07,-0.23027982,0.070265055
"Gamma carboxylation, hypusine formation and arylsulfatase activation",0.00027855407,5.0,0.00027855407,-0.11850369,-0.3563419
Hedgehog ligand biogenesis,4.8838505e-05,2.0,4.8838505e-05,-0.21088001,0.08417978
Heme degradation,2.8342874e-05,2.0,2.8342874e-05,-0.21912198,0.07826813
Plasma lipoprotein assembly,1.0362565e-06,4.0,1.0362565e-06,-0.23010288,-0.2674611
Amine-derived hormones,2.7728142e-10,4.0,2.7728142e-10,-0.23051949,-0.2677599
Transport of Mature Transcript to Cytoplasm,0.00082256866,3.0,0.00082256866,0.10026277,0.13842376
Transcriptional regulation of white adipocyte differentiation,7.5307153e-06,2.0,7.5307153e-06,-0.22749124,0.072265185
Protein repair,4.8955004e-05,2.0,4.8955004e-05,-0.21083315,0.08421338
Electric Transmission Across Gap Junctions,1.4028123e-07,2.0,1.4028123e-07,-0.23046319,0.07013352
Latent infection of Homo sapiens with Mycobacterium tuberculosis,0.0,2.0,0.0,-0.2305196,0.07009306
Signaling by FGFR in disease,2.2526778e-05,5.0,2.2526778e-05,-0.22146083,-0.430189
Neurotransmitter uptake and metabolism In glial cells,7.1015442e-09,2.0,7.1015442e-09,-0.23051675,0.070095114
Activation of Matrix Metalloproteinases,4.3562104e-05,2.0,4.3562104e-05,-0.21300183,0.08265787
"ROS, RNS production in phagocytes",8.424653e-06,2.0,8.424653e-06,-0.22713177,0.07252302
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),3.3066264e-08,2.0,3.3066264e-08,-0.2305063,0.0701026
Post-translational modification: synthesis of GPI-anchored proteins,0.00012970503,4.0,0.00012970503,-0.17836086,-0.23034856
HIV Infection,0.0030061633,3.0,0.0030061633,0.97835916,0.7682479
Advanced glycosylation endproduct receptor signaling,1.13941e-05,2.0,1.13941e-05,-0.22593765,0.07337952
Signaling by VEGF,0.00030794556,4.0,0.00030794556,-0.106684394,-0.17893785
KSRP (KHSRP) binds and destabilizes mRNA,8.783152e-06,2.0,8.783152e-06,-0.22698762,0.07262642
Endosomal Sorting Complex Required For Transport (ESCRT),0.0001786207,2.0,0.0001786207,-0.15869024,0.12161343
Meiotic synapsis,4.6177387e-08,2.0,4.6177387e-08,-0.23050104,0.07010638
Nucleotide salvage,0.0002380486,3.0,0.0002380486,-0.1347923,-0.030172018
Rho GTPase cycle,1.628016e-05,2.0,1.628016e-05,-0.2239728,0.07478882
Insulin effects increased synthesis of Xylulose-5-Phosphate,4.5448563e-05,2.0,4.5448563e-05,-0.21224321,0.083202
Caspase activation via extrinsic apoptotic signalling pathway,5.3367985e-05,3.0,5.3367985e-05,-0.20905855,-0.08344029
Intracellular oxygen transport,0.0,2.0,0.0,-0.2305196,0.07009306
RNA Polymerase III Abortive And Retractive Initiation,4.257852e-05,2.0,4.257852e-05,-0.21339737,0.08237418
Metabolism of polyamines,6.0385664e-05,7.0,6.0385664e-05,-0.2062365,-0.7571222
mRNA Capping,0.00015047558,2.0,0.00015047558,-0.17000833,0.11349542
Signaling by ROBO receptors,2.5019339e-05,9.0,2.5019339e-05,-0.2204585,-1.1051762
Cargo trafficking to the periciliary membrane,0.00017800042,5.0,0.00017800042,-0.15893967,-0.38534504
Gap junction trafficking and regulation,8.409579e-05,3.0,8.409579e-05,-0.19670187,-0.07457732
"Incretin synthesis, secretion, and inactivation",9.3004055e-05,3.0,9.3004055e-05,-0.19311956,-0.07200788
Stimuli-sensing channels,0.00040068527,2.0,0.00040068527,-0.069390655,0.18566455
IPs transport between nucleus and cytosol,0.0,2.0,0.0,-0.2305196,0.07009306
Butyrophilin (BTN) family interactions,9.4687414e-07,2.0,9.4687414e-07,-0.23013884,0.070366174
HuR (ELAVL1) binds and stabilizes mRNA,6.462534e-05,2.0,6.462534e-05,-0.20453158,0.08873324
Nucleobase biosynthesis,2.4063527e-06,3.0,2.4063527e-06,-0.22955193,-0.09813939
Regulation of gene expression in beta cells,3.5800444e-06,2.0,3.5800444e-06,-0.22907993,0.07112568
Biosynthesis of specialized proresolving mediators (SPMs),8.287233e-05,6.0,8.287233e-05,-0.19719386,-0.5817098
Diseases associated with surfactant metabolism,1.1406096e-06,8.0,1.1406096e-06,-0.2300609,-0.94313717
Vasopressin regulates renal water homeostasis via Aquaporins,0.0001394335,2.0,0.0001394335,-0.17444873,0.11031049
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,2.0035144e-05,2.0,2.0035144e-05,-0.2224628,0.07587189
PKMTs methylate histone lysines,0.00024611343,2.0,0.00024611343,-0.13154916,0.14108068
Positive epigenetic regulation of rRNA expression,4.083211e-07,3.0,4.083211e-07,-0.2303554,-0.098715685
C-type lectin receptors (CLRs),5.49489e-06,4.0,5.49489e-06,-0.22830993,-0.26617506
Signal amplification,0.00015810035,4.0,0.00015810035,-0.16694216,-0.22215839
Cell-cell junction organization,1.4955383e-06,4.0,1.4955383e-06,-0.2299182,-0.26732862
ER to Golgi Anterograde Transport,1.8787166e-05,4.0,1.8787166e-05,-0.22296466,-0.2623411
Resolution of Abasic Sites (AP sites),3.534389e-05,5.0,3.534389e-05,-0.21630666,-0.42649215
Presynaptic depolarization and calcium channel opening,1.9076144e-07,2.0,1.9076144e-07,-0.2304429,0.07014808
DAG and IP3 signaling,8.735291e-05,2.0,8.735291e-05,-0.19539207,0.09528866
Scavenging of heme from plasma,0.0021931513,2.0,0.0021931513,0.6514198,0.7026736
Diseases associated with glycosaminoglycan metabolism,6.0922923e-07,16.0,6.0922923e-07,-0.23027462,-2.2947025
Cell-extracellular matrix interactions,3.8892813e-06,3.0,3.8892813e-06,-0.2289556,-0.09771167
Transferrin endocytosis and recycling,0.0037788462,2.0,0.0037788462,1.2890809,1.1600429
Insulin processing,2.4619083e-05,2.0,2.4619083e-05,-0.22061944,0.077194065
mTORC1-mediated signalling,3.1543345e-06,2.0,3.1543345e-06,-0.22925113,0.071002886
Tie2 Signaling,1.4648389e-08,2.0,1.4648389e-08,-0.2305137,0.07009729
Phase I - Functionalization of compounds,0.00016626106,7.0,0.00016626106,-0.16366047,-0.7265841
Intrinsic Pathway for Apoptosis,5.9156777e-05,8.0,5.9156777e-05,-0.20673068,-0.9264032
Regulation of Apoptosis,5.9028406e-07,3.0,5.9028406e-07,-0.23028223,-0.09866321
G1/S DNA Damage Checkpoints,3.5102523e-05,3.0,3.5102523e-05,-0.2164037,-0.08870867
Diseases associated with glycosylation precursor biosynthesis,1.952307e-13,16.0,1.952307e-13,-0.2305196,-2.2948782
Ion transport by P-type ATPases,9.351778e-05,2.0,9.351778e-05,-0.19291298,0.09706682
Translocation of SLC2A4 (GLUT4) to the plasma membrane,1.5717917e-06,2.0,1.5717917e-06,-0.22988753,0.070546426
Voltage gated Potassium channels,5.6763696e-08,2.0,5.6763696e-08,-0.23049678,0.070109434
"Synthesis of IP2, IP, and Ins in the cytosol",0.00036507717,2.0,0.00036507717,-0.083709866,0.17539394
mRNA 3'-end processing,2.8287848e-05,2.0,2.8287848e-05,-0.2191441,0.07825226
Signaling by EGFR in Cancer,1.0598107e-05,4.0,1.0598107e-05,-0.22625774,-0.2647031
Formation of xylulose-5-phosphate,1.0049215e-05,2.0,1.0049215e-05,-0.22647847,0.0729916
PP2A-mediated dephosphorylation of key metabolic factors,1.2303782e-05,2.0,1.2303782e-05,-0.22557184,0.073641896
Threonine catabolism,3.8092475e-07,2.0,3.8092475e-07,-0.23036642,0.07020293
Smooth Muscle Contraction,0.009341418,2.0,0.009341418,3.5259771,2.7644808
tRNA processing in the mitochondrion,1.2811571e-06,2.0,1.2811571e-06,-0.2300044,0.0704626
Metabolic disorders of biological oxidation enzymes,9.586131e-07,33.0,2.9048882e-08,-0.23050793,-5.1663527
RNA Polymerase I Promoter Clearance,1.2389806e-05,4.0,1.2389806e-05,-0.22553726,-0.26418632
Extrinsic Pathway of Fibrin Clot Formation,2.1944943e-06,2.0,2.1944943e-06,-0.22963712,0.07072602
Receptor-type tyrosine-protein phosphatases,3.3399094e-05,2.0,3.3399094e-05,-0.21708871,0.07972652
MGMT-mediated DNA damage reversal,8.791052e-07,2.0,8.791052e-07,-0.23016608,0.07034663
Signaling by NOTCH4,0.0028960907,4.0,0.0028960907,0.9340953,0.5675726
Glucagon signaling in metabolic regulation,2.0433176e-06,2.0,2.0433176e-06,-0.22969791,0.07068243
Complement cascade,0.00036000548,5.0,0.00036000548,-0.08574936,-0.3328485
Recognition of DNA damage by PCNA-containing replication complex,1.8146084e-05,2.0,1.8146084e-05,-0.22322246,0.07532702
IRE1alpha activates chaperones,0.002798196,2.0,0.002798196,0.89472854,0.8771895
Neutrophil degranulation,9.093877e-05,2.0,9.093877e-05,-0.19395009,0.096322946
HDACs deacetylate histones,0.0006271482,2.0,0.0006271482,0.021677662,0.25098428
Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells,0.0,2.0,0.0,-0.2305196,0.07009306
RET signaling,1.7583053e-08,2.0,1.7583053e-08,-0.23051253,0.07009814
Phase 4 - resting membrane potential,3.0506176e-06,2.0,3.0506176e-06,-0.22929285,0.070972964
DNA strand elongation,2.0438747e-05,4.0,2.0438747e-05,-0.2223005,-0.26186472
Phase 1 - inactivation of fast Na+ channels,4.0044217e-08,2.0,4.0044217e-08,-0.2305035,0.070104614
Metabolism of Angiotensinogen to Angiotensins,3.6933445e-05,2.0,3.6933445e-05,-0.21566743,0.08074594
"Base-Excision Repair, AP Site Formation",0.00016478187,3.0,0.00016478187,-0.1642553,-0.051304676
"BMAL1:CLOCK,NPAS2 activates circadian gene expression",1.1473133e-07,2.0,1.1473133e-07,-0.23047346,0.07012616
Signaling by Retinoic Acid,4.1375937e-05,2.0,4.1375937e-05,-0.21388096,0.08202731
M Phase,0.00020679833,5.0,0.00020679833,-0.14735909,-0.37703875
Neurotransmitter receptors and postsynaptic signal transmission,1.385938e-05,6.0,1.385938e-05,-0.22494629,-0.6016155
Surfactant metabolism,6.9244816e-06,2.0,6.9244816e-06,-0.22773503,0.07209033
Scavenging by Class F Receptors,7.200621e-07,2.0,7.200621e-07,-0.23023003,0.07030076
DAP12 interactions,9.596302e-05,2.0,9.596302e-05,-0.19192967,0.09777211
Signaling by ERBB2,0.00045812505,9.0,0.00045812505,-0.046292197,-0.9802535
Heme biosynthesis,0.00027637242,2.0,0.00027637242,-0.11938101,0.1498084
Signaling by SCF-KIT,0.0001640078,2.0,0.0001640078,-0.16456658,0.117398575
Ion homeostasis,3.4576693e-05,2.0,3.4576693e-05,-0.21661516,0.08006618
Scavenging by Class A Receptors,1.4389762e-07,2.0,1.4389762e-07,-0.23046173,0.07013457
Regulation of signaling by NODAL,3.5879442e-12,2.0,3.5879442e-12,-0.2305196,0.07009306
trans-Golgi Network Vesicle Budding,0.00033658036,2.0,0.00033658036,-0.09516938,0.16717446
Netrin-1 signaling,8.5294094e-05,5.0,8.5294094e-05,-0.19622,-0.41208476
Interaction With The Zona Pellucida,3.256188e-10,2.0,3.256188e-10,-0.23051946,0.07009317
Diseases associated with visual transduction,3.4520486e-09,3.0,3.4520486e-09,-0.23051822,-0.09883247
Platelet sensitization by LDL,3.651177e-06,2.0,3.651177e-06,-0.22905134,0.07114619
CREB3 factors activate genes,0.00012368892,2.0,0.00012368892,-0.18078014,0.10576922
TYSND1 cleaves peroxisomal proteins,0.004103159,2.0,0.004103159,1.4194978,1.2535859
"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",5.1199385e-07,3.0,5.1199385e-07,-0.2303137,-0.09868579
Pyruvate metabolism and Citric Acid (TCA) cycle,0.0006743698,4.0,0.0006743698,0.04066705,-0.07324844
Metabolism of steroids,1.0000326e-05,6.0,1.0000326e-05,-0.22649814,-0.6027286
RNA Polymerase III Transcription Termination,7.4041145e-06,2.0,7.4041145e-06,-0.22754215,0.07222867
Influenza Infection,2.8617269e-05,3.0,2.8617269e-05,-0.21901163,-0.09057925
IPs transport between nucleus and ER lumen,0.0,2.0,0.0,-0.2305196,0.07009306
Fanconi Anemia Pathway,0.009186473,2.0,0.009186473,3.4636683,2.719789
Signaling by TGF-beta Receptor Complex,0.00091313507,4.0,0.00091313507,0.13668254,-0.004380284
RNA Polymerase II Pre-transcription Events,2.5620812e-08,2.0,2.5620812e-08,-0.2305093,0.07010046
Signaling by WNT in cancer,8.3967076e-05,11.0,8.3967076e-05,-0.19675364,-1.4260266
Signaling by PDGF,2.4521546e-06,2.0,2.4521546e-06,-0.2295335,0.07080036
Signaling by NOTCH2,0.0023897658,3.0,0.0023897658,0.73048514,0.59045756
Branched-chain amino acid catabolism,5.1064427e-07,2.0,5.1064427e-07,-0.23031425,0.07024035
Fatty acid metabolism,2.5329291e-05,7.0,2.5329291e-05,-0.22033384,-0.76723367
Metallothioneins bind metals,0.0,2.0,0.0,-0.2305196,0.07009306
Signaling by the B Cell Receptor (BCR),6.811717e-06,4.0,6.811717e-06,-0.22778039,-0.26579526
Activation of anterior HOX genes in hindbrain development during early embryogenesis,0.00023175514,2.0,0.00023175514,-0.13732311,0.13693926
AMPK inhibits chREBP transcriptional activation activity,2.539943e-05,2.0,2.539943e-05,-0.22030564,0.07741915
SLBP independent Processing of Histone Pre-mRNAs,1.9403383e-06,2.0,1.9403383e-06,-0.22973932,0.07065272
Sperm Motility And Taxes,3.1090204e-09,2.0,3.1090204e-09,-0.23051836,0.07009396
Apoptotic execution phase,0.0006141321,4.0,0.0006141321,0.01644345,-0.09062308
Cellular Senescence,0.0051128976,5.0,0.0051128976,1.8255475,1.0380498
Signaling by ERBB4,0.0011199213,5.0,0.0011199213,0.21983822,-0.11366251
Prostacyclin signalling through prostacyclin receptor,8.942211e-06,2.0,8.942211e-06,-0.22692364,0.07267231
Signal regulatory protein family interactions,0.00045023847,2.0,0.00045023847,-0.049463656,0.1999574
Inhibition of TSC complex formation by PKB,1.0952611e-08,2.0,1.0952611e-08,-0.2305152,0.070096225
O-linked glycosylation,5.3090233e-05,3.0,5.3090233e-05,-0.20917025,-0.083520405
GP1b-IX-V activation signalling,6.867958e-05,2.0,6.867958e-05,-0.20290124,0.089902624
Laminin interactions,2.1913031e-07,2.0,2.1913031e-07,-0.23043147,0.070156276
Post-chaperonin tubulin folding pathway,1.7798854e-07,2.0,1.7798854e-07,-0.23044802,0.07014441
Phenylketonuria,0.0,2.0,0.0,-0.2305196,0.07009306
Interferon Signaling,4.7923782e-05,4.0,4.7923782e-05,-0.21124785,-0.25393713
MAPK1/MAPK3 signaling,0.0017997838,3.0,0.0017997838,0.49323368,0.42028636
Metabolism of fat-soluble vitamins,9.094923e-08,4.0,9.094923e-08,-0.23048304,-0.26773375
Platelet Adhesion to exposed collagen,0.000118503405,2.0,0.000118503405,-0.18286541,0.104273535
Neddylation,8.5997635e-05,2.0,8.5997635e-05,-0.19593708,0.09489775
p75 NTR receptor-mediated signalling,0.0001436447,8.0,0.0001436447,-0.17275527,-0.90203404
mRNA decay by 3' to 5' exoribonuclease,1.1551118e-06,2.0,1.1551118e-06,-0.23005508,0.07042625
Chaperonin-mediated protein folding,0.004380315,4.0,0.004380315,1.5309515,0.99567425
Signaling by NOTCH1 in Cancer,0.000114703456,6.0,0.000114703456,-0.1843935,-0.57252854
Carboxyterminal post-translational modifications of tubulin,2.606255e-05,2.0,2.606255e-05,-0.22003898,0.0776104
Intrinsic Pathway of Fibrin Clot Formation,0.00014023129,2.0,0.00014023129,-0.1741279,0.1105406
Generic Transcription Pathway,8.597313e-06,11.0,8.597313e-06,-0.22706233,-1.4477658
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,1.2069147e-05,2.0,1.2069147e-05,-0.2256662,0.073574215
Eukaryotic Translation Elongation,0.00018362187,2.0,0.00018362187,-0.1566791,0.12305596
Semaphorin interactions,0.00012814034,6.0,0.00012814034,-0.1789901,-0.5686529
Anchoring of the basal body to the plasma membrane,0.0020712826,2.0,0.0020712826,0.60241234,0.6675225
RNA polymerase II transcribes snRNA genes,6.675972e-07,2.0,6.675972e-07,-0.23025115,0.07028562
CDO in myogenesis,0.000408999,2.0,0.000408999,-0.06604742,0.18806252
Signaling by MST1,0.0,2.0,0.0,-0.2305196,0.07009306
IPs transport between ER lumen and cytosol,0.0,2.0,0.0,-0.2305196,0.07009306
Pink/Parkin Mediated Mitophagy,0.00061317254,2.0,0.00061317254,0.016057583,0.24695322
Cytosolic iron-sulfur cluster assembly,1.593389e-05,2.0,1.593389e-05,-0.22411205,0.07468895
Neurotransmitter release cycle,6.6534917e-06,7.0,6.6534917e-06,-0.22784401,-0.77262044
